US Patent

US9241948 — Ready to be infused gemcetabine solution

Formulation · Assigned to Sun Pharmaceutical Industries Ltd · Expires 2033-07-01 · 7y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a large volume infusion dosage form of gemcitabine, a stable solution ready to be infused.

USPTO Abstract

A large volume infusion dosage form of gemcitabine, comprising a stable large volume solution of gemcitabine or its pharmaceutically acceptable salt in an aqueous vehicle filled in a large volume infusion container, wherein the solution is ready-to-be-infused.

Drugs covered by this patent

Patent Metadata

Patent number
US9241948
Jurisdiction
US
Classification
Formulation
Expires
2033-07-01
Drug substance claim
No
Drug product claim
Yes
Assignee
Sun Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.